Oral administration to diet-induced-obese mice for ~10 days reduces fat mass without altering food intake, decreases adipocyte size, restores insulin sensitivity, and increases adipose NAD and SAM levels [2]
[2] [7] Treatment response should be monitored through clinical improvement, reticulocyte count (which typically rises within a week), and full blood count after 8 weeks
Similarly, documented methodologies support accurate communication, reliable reporting practices, and repeatable analytical workflows
You can administer an intramuscular injection in your deltoid muscle, upper thigh, or outer hip
Clinical trial safety data: In the Phase 2 trial, adverse events were comparable to placebo